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Abstract
Sera from 105 anti-HCV-positive ﬁrst-time blood donors col-
lected in 2004, 2005 and 2008 in different provinces in Laos
were investigated by PCR. Forty-ﬁve samples were positive for
HCV (42.86%); two belonged to subtype 1b (2/45, 4.4%) and all
others to genotype 6 (43/45, 95.6%), including subtypes 6b, 6h,
6k, 6l, 6n and 6q. Three groups of sequences were not clearly
attributable to any genotype 6 subtype, two of which may be
regarded as candidates for new subtypes of genotype 6. Two
samples were mixed infected with different subtypes or clusters
of genotype 6 viruses.
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Hepatitis C virus (HCV) is a major cause of liver cirrhosis
and hepatocellular carcinoma worldwide. It is estimated that
up to 3% of the world’s population are infected with HCV
[1]. Currently, six genotypes of HCV are recognized [2] and
a seventh has been proposed [3]. While some of the geno-
types, such as 1, 2 and 3, are found worldwide, others show
a geographically more restricted prevalence [4–6]. Genotype
6, which is found throughout East Asia, is by far the most
variable genotype, with at least 23 proposed subtypes (a–w)
[2,4,5,7–12]. While HCV genotypes have been well studied
in some East Asian countries such as China [13–15] or Thai-
land [7,16,17], only a few strains have been reported from
other countries [5].
Forty-eight, 52 and ﬁve serum samples were collected
from anti-HCV-positive ﬁrst-time blood donors in 2004,
2005 and 2008, respectively. Seventy-eight sera were from
men, 27 from women. The majority of the donors were resi-
dents of Vientiane city (n = 73), the others lived in Vientiane
province (n = 14), Borikhamxay province (n = 13) and in
Luang Prabang province (n = 5). The age of the donors ran-
ged from 17 to 57 years (mean, 30.2).
Ampliﬁcation of the HCV core/E1 gene region was done
as described before [18], with the exception that 1 lL of
cDNA was used for the ﬁrst-round PCR and 1 lL of ﬁrst-
round product for the semi-nested PCR. The NS5B region
was ampliﬁed according to Sandres-Saune et al. [19], but
using an annealing temperature of 60C for all cycles. The
primers used to amplify the core/E1 region were used previ-
ously to amplify 1a, 1b, 3a, 4a and 4d sequences [18] and the
NS5B primers previously ampliﬁed 1a, 1b, 1c, 2a, 2b, 2c, 2k,
3a, 4a, 4d, 4f, 4i and 5a [19]. Samples suspected to be mixed
infected were cloned using the pCR4-TOPO kit (Invitrogen,
Merelbeke, Belgium). Phylogenetic analysis was performed
using MEGA4 [20] and GENEIOUS PRO5.3.4 (Biomatters Ltd,
Auckland, New Zealand). Distance calculations were also
done with MEGA4.
Of the 105 anti-HCV-positive donors 35 and 44 were
RNA positive using the core/E1 and the NS5B gene PCRs,
respectively. Thirty-ﬁve and 40 fragments suitable for phylo-
genetic analysis were obtained from these regions. From 30
samples, sequences of both regions were available (GenBank
accession numbers for all sequences: HE580284–HE580419).
Phylogenetic analysis of the 865 nt region of the core/E1
gene showed that two samples (47054 and the clones of
47015) belonged to genotype 1, subtype 1b, and that all oth-
ers belonged to genotype 6 (Fig. 1a). One sample each was
attributed to subtypes 6h (47052), 6n (47069), 6l (47013) and
6k (one set of clones from 47098), two samples to 6q
(47087, 47036) and three to 6b (47011, 47017 and the clones
of 47049) (Fig. 1a). The other sequences could not be clearly
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FIG. 1. Phylogenetic tree based on (a) 865 nt of the HCV core/E1 gene region and (b) 340 nt of the NS5B region. Neighbour-joining and
Kimura two parameter methods were used and only bootstrap values ‡70 are shown. The clustering was largely conﬁrmed by different phylo-
genetic methods, except that the two clusters of unassigned group 3 were sometimes separated. Sequences obtained during the present study
are marked in black (dots are used for original sequences; diamonds, triangles and squares for clones), and the closest BLAST ﬁts are shown as
open symbols (squares are from sequences in unassigned group 1, triangles from sequences in unassigned group 2 and diamonds from sequences
in unassigned group 3).
CMI Research Note E31
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, E30–E34
FIG. 1. (Continued)
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assigned to a genotype 6 subtype based on this analysis
(Fig. 1a, unassigned groups 1–3). Of the ﬁve samples sus-
pected to be mixed infected based on the original sequence
data (47049, 47053, 47098, 47083 and 47015), only one
(47098) was conﬁrmed by the different clustering of the
clones: one set with subtype 6k, the other set in unassigned
group 3 (Fig. 1a).
Phylogenetic analysis of 340 nt of the NS5B region
assigned two strains (47015 and 47054) to 1b and all others
to genotype 6 (Fig. 1b). One strain each belonged to 6h
(47070), 6n (47069), 6k (47098), 6l (clones of 47013) and 6q
(47087) and three sequences to 6b (47011, 47026, 47017).
The other 30 strains clustered inconclusively (Fig. 1b, unas-
signed groups 1–3). Of the three suspected mixed infected
samples (47013, 47067 and 47078), only the clones of 47078
clustered differently (with the ﬁrst and second set of unas-
signed sequences, Fig. 1b), conﬁrming the mixed infection.
There was a good overall agreement between the results
obtained for the two different genomic regions with only
two sequences showing a distinct clustering (47049, core/E1,
6b; NS5B, unassigned group 1; 47067, core/E1, second clus-
ter of the ﬁrst unassigned group; NS5B, ﬁrst cluster of the
ﬁrst unassigned group) (Fig. 1).
Genotype 6 of HCV is largely predominant in Laos (43/45,
95.6%), while only two sequences of the worldwide preva-
lent subtype 1b were found and no subtype 3a, which was
suggested to be the most common subtype in south-east
Asia [7]. Thus, the genotype prevalence in Laos is quite dis-
tinct from that in the surrounding countries, which may be
due to less exposure to public health mass interventions [5].
The six genotype 6 subtypes detected in the present study
were reported previously mainly from south-east Asia and
none of them seems to be restricted to Laos [5,7]. Unas-
signed group 1 seems to represent a distinct cluster of 6j or
6i, due to its clustering in the phylogenetic trees of Fig. 1
and its minimal genetic distance of <15% to subtype 6j
(Table 1). More sequences similar to outlier 56774 are
needed before the status of this distinct strain can be
resolved. Groups 2 and 3 may be considered as candidates
for new subtypes of genotype 6. Both have high genetic dis-
tances (at least 18.5%) to the next closest subtypes (Table 1)
and each group contains sequences from several individuals
from different non-contiguous regions in Laos (group 2,
donors from two different districts of Vientiane city and
from Luang Prabang (56518); group 3, donors from three dif-
ferent districts of Vientiane city and from Borikhamxay prov-
ince (47098)) and even sequences from different countries
(group 2, Laos and Vietnam; group 3, Laos, Vietnam and
Canada). The high maximal genetic distance between the
Laos strains within the two groups (at least 21.3%) and the
interspersed clustering with sequences from the other coun-
tries, as well as circumstantial evidence, virtually exclude a
direct transmission between the donors. No amino acid
mutations speciﬁc for and exclusively found in the Laos
strains of unassigned groups 2 and 3 were found. Thus the
designation as a new subtype would be of epidemiological
value according to the criteria proposed by Simmonds et al.
[2]. As the two clusters of group 3 differ by at least 19%
from each other and by at least 18.3% from the next closest
subtypes (Table 1), it is conceivable that group 3 comprises
two new potential subtypes.
In the present study, less than half of the samples from
anti-HCV-positive blood donors were also PCR positive (45/
105, 42.86%). In some donors this may result from spontane-
ously controlled HCV replication after acute infection [1],
but may in part also be due to suboptimal storage.
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